All experiments were carried out in the DF5 strain background (Finley et al., 1987 (link)). All strains used are listed in Table S2 (see Supporting information). Standard procedures were followed for yeast cultivation and transformation (Sherman, 1991 (link)). For use of the CUP1 promoter, 100 µM CuSO4 was added to the growth medium. Geneticin was used at 200 µg/ml (for kanMX4 selection); hygromycin B at 300 µg/ml (for hphNT1); and nourseothricin at 100 µg/ml (for natNT2). Auxin was used at 1 mm unless otherwise indicated. TIR1 strains were created by integration of pNHK53 (encoding OsTIR1 under control of the ADH1 promoter) into the URA3 locus (Nishimura et al., 2009 (link)). All strains carrying a deletion or epitope-tagged allele of RAD53 were constructed in an sml1Δ background. Gene deletions and tags were introduced by means of PCR-generated cassettes (Longtine et al., 1998 (link)), using the primers listed in Table S1 (see Supporting information).
>
Chemicals & Drugs
>
Amino Acid
>
Nourseothricin
Nourseothricin
Nourseothricin is a natural product antibiotric derived from the bacterium Streptomyces noursei.
It is an inhibitor of protein synthesis and has been used as a selection marker in genetic engineering.
The chemical structure of nourseothricin consists of an aminoglycsoide core linked to a peptide moiety.
Nourseothricin has potent antimicrobial activity against a wide range of Gram-positive and Gram-negative bacteria, as well as some fungi.
It is commonly employed in molecular biology techniques, such as vector construction and cell line development, to selct for trasnformed cells.
Reseach on the applications and mechanisms of nourseothricin is an active area of study.
It is an inhibitor of protein synthesis and has been used as a selection marker in genetic engineering.
The chemical structure of nourseothricin consists of an aminoglycsoide core linked to a peptide moiety.
Nourseothricin has potent antimicrobial activity against a wide range of Gram-positive and Gram-negative bacteria, as well as some fungi.
It is commonly employed in molecular biology techniques, such as vector construction and cell line development, to selct for trasnformed cells.
Reseach on the applications and mechanisms of nourseothricin is an active area of study.
Most cited protocols related to «Nourseothricin»
Alleles
Auxins
Culture Media
Deletion Mutation
Epitopes
Gene Deletion
Geneticin
Hygromycin B
Nourseothricin
Oligonucleotide Primers
Saccharomyces cerevisiae
Strains
To construct the pNAT plasmid, plasmid pCJN542 (16 (link)) was cut with SacI and SpeI to remove the TDH3 promoter. The SacI-SpeI fragment containing the nourseothricin resistance cassette (NAT) was blunted and self-ligated (17 ) to yield plasmid pNAT. The plasmid pV1093 used in this study was a kind gift from Valmik Vyas (3 (link)). We cloned the 20-bp guide sequence for ADE2 into the pV1093 vector, yielding pADE2-sgRNA. The CaCAS9 gene was the CAS9 gene that had been codon optimized for expression in C. albicans (3 (link)). The CaCAS9 expression cassette containing the ENO1 promoter, CaCAS9 open reading frame (ORF), and CYC1 terminator was PCR amplified from plasmid pV1093 (Fig. 2A ). The sgRNA expression cassette containing the SNR52 promoter, guide sequence, and sgRNA scaffold sequence was assembled by the single-joint PCR method (11 (link)). In the first step, the SNR52 promoter and sgRNA scaffold components were PCR amplified using both flanking primers and internal chimeric primers (Fig. 3 ). The chimeric primers overlapped by a 20-base segment that specified the guide sequence. In the second step, both components were joined by primer extension, relying upon annealing of the complementary chimeric primer extensions. In the third step, the joined product was PCR amplified with nested primers to yield the sgRNA cassette (Fig. 3 ). Gene deletion PCR constructs were synthesized using plasmid pNAT or pRS-ARG4 (15 (link)) or the CdARG4 plasmid pSN105 (10 (link)), modified slightly, as the template. The primers were designed to include 80 bases with homology to the sequences upstream or downstream from the target gene (Fig. 2B ). The oligonucleotides used in this study are listed in Table S1 in the supplemental material. PCR was conducted with Ex Taq in accordance with the manufacturer’s instructions (TaKaRa Bio, Inc.).
Full text: Click here
Candida albicans
Chimera
Cloning Vectors
Codon
Gene Deletion
Genes
Joints
NAT2 protein, human
Nourseothricin
Oligonucleotide Primers
Oligonucleotides
Plasmids
Thyroid Dyshormonogenesis 3
All of the C. albicans strains used in this study were derived from strain SC5314, and a complete list of the strains is provided in Table S2 . nourseothricin-sensitive C. albicans strains were cultured in yeast extract-peptone-dextrose (YPD) liquid medium at 30°C and harvested at an optical density at 600 nm between 0.5 and 0.8 prior to transformation by a modified version of the standard lithium acetate protocol (10 ); see our detailed protocol in Text S1 . After recovery in liquid YPD for 5 h, nourseothricin-resistant transformants were selected on YPD agar supplemented with 200 µg/ml nourseothricin (GoldBio). Subsequent removal of the CRISPR components was performed by single-colony isolation on synthetic defined (SD) agar medium minus leucine for the LEUpOUT method or by culturing overnight in YP-maltose liquid medium, followed by screening on YPD agar supplemented with 25 µg/ml nourseothricin for the FLP recombinase-mediated method (see Text S1 for details). The generation of homozygous URA3 deletion strains was confirmed by patching to SD minus uracil versus YPD plates; both medium types were supplemented with 200 µg/ml nourseothricin to maintain selection for strains that had integrated the CRISPR components. All E. coli strains were derived from DH5α and cultured at 37°C in LB medium supplemented with 100 µg/ml carbenicillin.
Full text: Click here
Agar
Carbenicillin
Clustered Regularly Interspaced Short Palindromic Repeats
Culture Media
Deletion Mutation
Escherichia coli
FLP recombinase
Glucose
Homozygote
isolation
Leucine
lithium acetate
Maltose
Nourseothricin
Peptones
Strains
Uracil
Yeasts
The codon‐optimized genes, encoding the pyruvate dehydrogenase complex and lipoate‐protein ligase from Enterococcus faecalis, were ordered from GenScript (sequences can be found in Supporting information, Table S5). The genes encoding ATP‐dependent citrate lyase and the mitochondrial citrate transport protein, were amplified from the genomic DNA of Yarrowia lipolytica DSM‐8218, obtained from the DSMZ collection (www.dsmz.de ). All of the primers, biobricks and plasmids constructed and used in this study can be found in Supporting information, Tables S1–S3.
The EasyClone‐MarkerFree vectors were created by amplifying the EasyClone 2.0 vectors6 with primers that were designed to attach to either side of the selection markers, creating a fragment that no longer contained the marker. These fragments were then ligated to form the marker‐less vectors. Seven of the resulting vectors (named ”Intermediate vectors“ in Table S3) contained PAM sites in the integration regions, which were removed by site‐directed mutagenesis using the QuikChange II XL Site‐Directed Mutagenesis Kit (Agilent Technologies) according to the manufacturers' protocol.
gRNA cassettes targeting particular integration loci (chromosomal coordinates can be found in Supporting information, Table S4) were ordered as double‐stranded gene blocks from IDT DNA. These cassettes were amplified using primers 10525(TJOS‐62 [P1F]) and 10529(TJOS‐65 [P1R]) and USER‐cloned into pCfB2926 (pTAJAK‐71)15 to give single gRNA helper vectors. For construction of triple gRNA helper vectors, three gRNA cassettes were amplified using three primer pairs (10525(TJOS‐62 [P1F]) and 10530(TJOS‐66 [P2R]) for the first, 10526(TJOS‐63 [P2F]) and 10531(TJOS‐67 [P3R]) for the second, and 10527(TJOS‐64 [P3F]) and 10529(TJOS‐65 [P1R]) for the third gRNA cassette) and cloned into pCfB2926 (p‐TAJAK‐71) 15 . Single gRNA helper vectors for Ethanol Red were constructed by PCR amplification of the template plasmid pCfB3041 using primers indicated in Supporting information, Table S1 as described in 17 . All of the cloning steps for creating gRNA helper vectors and EasyClone‐MarkerFree vectors were performed in E. coli. Correct cloning was confirmed by Sanger sequencing.
For expression of the Cas9 gene we used an episomal vector pCfB2312 with CEN‐ARS replicon and KanMX resistance marker17 .
The EasyClone‐MarkerFree vectors for expression of fluorescent protein or 3HP pathway genes were cloned as described in5 , 26 . The vectors were linearized with NotI, the integration fragment (part of the expression vector without E. coli ori and AmpR) was gel‐purified and transformed, along with a gRNA helper vector, into yeast carrying the Cas9 plasmid (pCfB2312) via the lithium acetate method 27 . After the heat shock the cells were recovered for two hours in YPD medium and then plated on YPD agar containing 200 mg/L G418 and 100 mg/L nourseothricin. For yeast transformations with a single vector we routinely use 500 ng of the linear integration fragment along with 500 ng of the relevant gRNA helper plasmid. For yeast transformations with three vectors we use 1 µg of linear integration fragments and 1 µg of triple gRNA helper plasmid. Correct integration of the vectors into the genome was verified by colony PCR using primers listed in Supporting information, Table S1.
The EasyClone‐MarkerFree vectors were created by amplifying the EasyClone 2.0 vectors
gRNA cassettes targeting particular integration loci (chromosomal coordinates can be found in Supporting information, Table S4) were ordered as double‐stranded gene blocks from IDT DNA. These cassettes were amplified using primers 10525(TJOS‐62 [P1F]) and 10529(TJOS‐65 [P1R]) and USER‐cloned into pCfB2926 (pTAJAK‐71)
For expression of the Cas9 gene we used an episomal vector pCfB2312 with CEN‐ARS replicon and KanMX resistance marker
The EasyClone‐MarkerFree vectors for expression of fluorescent protein or 3HP pathway genes were cloned as described in
Full text: Click here
Agar
antibiotic G 418
ATP Citrate (pro-S)-Lyase
Carrier Proteins
Cells
Chromosomes
Citrates
Cloning Vectors
Codon
Enterococcus faecalis
Episomes
Escherichia coli
Ethanol
Gene Expression
Genes
Genes, Duplicate
Genome
Heat-Shock Response
lipoate-protein ligase
lithium acetate
Mitochondria
Mutagenesis, Site-Directed
Nourseothricin
Oligonucleotide Primers
Plasmids
Proteins
Pyruvate Dehydrogenase Complex
Replicon
Saccharomyces cerevisiae
Yarrowia lipolytica
Saccharomyces cerevisiae strains were transformed according to Gietz and Woods (2002 ). Mutants were selected on solid YP medium (demineralized water, 10 g·L−1 Bacto yeast extract, 20 g·L−1 Bacto peptone, 2% (w/v) agar), supplemented with 200 mg·L−1 G418, 200 mg·L−1 hygromycin B or 100 mg·L−1 nourseothricin (for dominant markers) or on SM supplemented with appropriate auxotrophic requirements (Verduyn et al.1992 (link)). In all cases, gene deletions and integrations were confirmed by colony PCR on randomly picked colonies, using the diagnostic primers listed in Table S1 (Supplementary data). Integration of cas9 into the genome was achieved via assembly and integration of two cassettes containing cas9 and the natNT2 marker into the CAN1 locus. The cas9 cassette was obtained by PCR from p414-TEF1p-cas9-CYC1t (DiCarlo et al.2013b (link)), using primers 2873 & 4653. The natNT2 cassette was PCR amplified from pUG-natNT2 with primers 3093 & 5542. 2.5 μg cas9 and 800 ng natNT2 cassette were pooled and used for each transformation. Correct integration was verified by colony PCR (Supplementary data) using the primers given in Table S1 (Supplementary data), the resulting strains have been deposited at EUROSCARF. IMX719 was constructed by co-transformation of pUDR022 (see below) with genes required for functional Enterococcus faecalis PDH expression (Kozak et al.2014b (link)). The gene cassettes were obtained by PCR using plasmids pUD301–pUD306 as template (Table 2 ) with the primers indicated in Table S1 (Supplementary data) and the ACS1 dsDNA repair fragment, obtained by annealing two complementary single-stranded oligos (6422 & 6423). After confirmation of the relevant genotype (Fig. 4B ), the pUDR022 plasmid was removed as explained in Supplementary data.
Full text: Click here
2',5'-oligoadenylate
ACSL1 protein, human
Agar
antibiotic G 418
Bacto-peptone
Diagnosis
DNA, Double-Stranded
Enterococcus faecalis
Gene Deletion
Genes
Genome
Genotype
Hygromycin B
Nourseothricin
Oligonucleotide Primers
Plasmids
Saccharomyces cerevisiae
Strains
Most recents protocols related to «Nourseothricin»
Strains not associated with the library are summarized in Supplementary file 8 . C. albicans transformations were performed using the standard lithium acetate transformation method (Noble and Johnson, 2005 (link)). The single and double homozygous mutant strains of C. albicans were constructed from an SN152 background using the transient CRISPR/Cas9 method (Min et al., 2016 (link)). Oligonucleotides and plasmids used to generate the mutant strains in this study are listed in Supplementary file 9 . Briefly, the ume6∆∆ mutant strain was generated by deleting one copy of UME6 with HIS1 cassette which was amplified from pFA-LHL plasmid (Dueñas-Santero et al., 2019 (link)) with primer pairs UME6.P1 and UME6.2. The second allele of UME6 was replaced with the ARG4 marker amplified from pFA-LAL (Min et al., 2016 (link)) plasmid with primer pairs UME6.P1 and UME6.P2 and by using sgRNA targeting individual alleles of UME6 gene.
The brg1∆∆ mutant strain was generated by amplifying ARG4 cassette from pSN69 plasmid (Noble and Johnson, 2005 (link)) with primer pairs BRG1.P1 and BRG1.P2 and by using sgRNA targeting two alleles of BRG1 gene. The rob1∆∆ homozygous strain was generated by amplifying HIS1 cassette from the pSN52 plasmid (Noble and Johnson, 2005 (link)) with primer pairs ROB1.P1 and ROB1.P2 by using sgRNA targeting two alleles of ROB1 gene. The resulting brg1∆∆ and rob1∆∆ mutants were further used to generate double homozygous brg1∆∆ nrg1∆∆ and rob1∆∆ nrg1∆∆. To do this, both copies of NRG1 knocked out by amplifying HIS1 or ARG4 cassette from the plasmid pFA-LHL or pFA-LAL, respectively, with primer pairs NRG1.P1 and NRG1.P2 and using sgRNA targeting two alleles of NRG1 gene. The efg1∆∆ mutant strain from Homann collection (Homann et al., 2009 (link)) was used to generate the double homozygous efg1∆∆ nrg1∆∆ mutant. To do this, pFA-LAL plasmid was used to amplify the ARG4 cassette using NRG1.P1 and NRG1.P2 primer pairs and using sgRNA targeting two alleles of NRG1 gene. The resultant transformants were selected on the SD plates lacking either histidine or arginine. The single or double homozygous integration of the deletion cassette was confirmed by standard PCR methods.
Fluorescently labeled strains were generated by using pENO1-NEON-NAT1 and pENO1-iRFP-NAT1 plasmids as previously described (Bergeron et al., 2017 (link); Seman et al., 2018 (link)) and the resultant transformants were selected on YPD containing 200 µg/ml nourseothricin (Werner Bioagents, Jena, Germany). The reference strain was tagged with green fluorescent protein (NEON) whereas all the TF mutants were tagged with iRFP.
The brg1∆∆ mutant strain was generated by amplifying ARG4 cassette from pSN69 plasmid (Noble and Johnson, 2005 (link)) with primer pairs BRG1.P1 and BRG1.P2 and by using sgRNA targeting two alleles of BRG1 gene. The rob1∆∆ homozygous strain was generated by amplifying HIS1 cassette from the pSN52 plasmid (Noble and Johnson, 2005 (link)) with primer pairs ROB1.P1 and ROB1.P2 by using sgRNA targeting two alleles of ROB1 gene. The resulting brg1∆∆ and rob1∆∆ mutants were further used to generate double homozygous brg1∆∆ nrg1∆∆ and rob1∆∆ nrg1∆∆. To do this, both copies of NRG1 knocked out by amplifying HIS1 or ARG4 cassette from the plasmid pFA-LHL or pFA-LAL, respectively, with primer pairs NRG1.P1 and NRG1.P2 and using sgRNA targeting two alleles of NRG1 gene. The efg1∆∆ mutant strain from Homann collection (Homann et al., 2009 (link)) was used to generate the double homozygous efg1∆∆ nrg1∆∆ mutant. To do this, pFA-LAL plasmid was used to amplify the ARG4 cassette using NRG1.P1 and NRG1.P2 primer pairs and using sgRNA targeting two alleles of NRG1 gene. The resultant transformants were selected on the SD plates lacking either histidine or arginine. The single or double homozygous integration of the deletion cassette was confirmed by standard PCR methods.
Fluorescently labeled strains were generated by using pENO1-NEON-NAT1 and pENO1-iRFP-NAT1 plasmids as previously described (Bergeron et al., 2017 (link); Seman et al., 2018 (link)) and the resultant transformants were selected on YPD containing 200 µg/ml nourseothricin (Werner Bioagents, Jena, Germany). The reference strain was tagged with green fluorescent protein (NEON) whereas all the TF mutants were tagged with iRFP.
Full text: Click here
Alleles
Arginine
Candida albicans
Clustered Regularly Interspaced Short Palindromic Repeats
Deletion Mutation
DNA Library
Genes
Green Fluorescent Proteins
Histidine
Homozygote
lithium acetate
NAT1 protein, human
Neon
Nourseothricin
NRG1 protein, human
Oligonucleotide Primers
Oligonucleotides
Plasmids
SMARCA4 protein, human
Strains
Transients
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Animals, Transgenic
Clone Cells
Ficoll
Hamsters
Leishmaniasis, Visceral
Nourseothricin
Parasites
Patients
Plasmids
Shuttle Vectors
Strains
Virulence
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Clustered Regularly Interspaced Short Palindromic Repeats
FLP recombinase
Maltose
Nitrogen
Nourseothricin
Oligonucleotide Primers
Saccharomyces cerevisiae
Serum Albumin, Bovine
Strains
Transients
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Base Pairing
Clustered Regularly Interspaced Short Palindromic Repeats
Introns
Nourseothricin
Oligonucleotide Primers
Sepharose
Strains
Transients
Protocol full text hidden due to copyright restrictions
Open the protocol to access the free full text link
Alleles
Clustered Regularly Interspaced Short Palindromic Repeats
Nourseothricin
Oligonucleotide Primers
Strains
Transients
Top products related to «Nourseothricin»
Sourced in Germany
Nourseothricin is a selectable marker used in molecular biology and genetic engineering. It is an antibiotic that confers resistance to the host organism, allowing for the selection and identification of successfully transformed cells.
Sourced in United States, Germany, United Kingdom, France, China, Switzerland, Sao Tome and Principe, Spain, Ireland, India, Italy, Japan, Brazil, Australia, Canada, Macao, Czechia, New Zealand, Belgium, Cameroon, Austria, Israel, Norway, Denmark, Netherlands
Ampicillin is a broad-spectrum antibiotic used in laboratory settings. It is a penicillin-based compound effective against a variety of gram-positive and gram-negative bacteria. Ampicillin functions by inhibiting cell wall synthesis, leading to bacterial cell lysis and death.
Sourced in United States, Germany, United Kingdom, France, Italy, Japan, China, Canada, Spain, Denmark, Switzerland, Australia
Zeocin is a selective antibiotic agent used for screening and selection of transformed cells. It acts as a lethal agent against non-transformed cells, allowing for the identification and isolation of successfully transformed cells.
Sourced in United States
Nourseothricin is a selection marker for use in bacterial and eukaryotic cells. It confers resistance to the antibiotic nourseothricin, allowing for the selection of cells that have successfully integrated the desired genetic material.
Sourced in France, Germany, United States, China
Nourseothricin is a selective antibiotic used as a laboratory tool for genetic selection and screening. It inhibits protein synthesis in eukaryotic cells, enabling its use as a selectable marker in genetic engineering and cell line development.
Sourced in United States, United Kingdom, France, Germany, China, Japan, Switzerland, Italy, Austria, Australia
Hygromycin B is a laboratory reagent used for antibiotic selection during genetic engineering and cell culture experiments. It is a broad-spectrum aminoglycoside antibiotic that inhibits protein synthesis in eukaryotic cells. Hygromycin B is commonly used as a selectable marker in the generation of transgenic cell lines and organisms.
Sourced in United States, France, Germany, United Kingdom, Canada, Belgium, Australia, Japan, Switzerland, Spain, Italy, Sweden, Thailand
Geneticin is a broad-spectrum antibiotic used for the selection of mammalian, plant, and bacterial cells that have been successfully transfected with a gene of interest. It acts by inhibiting protein synthesis and is commonly used in cell culture applications to identify and maintain cells that have been genetically modified.
Sourced in United States, Germany, United Kingdom, Czechia, Italy, China, France, Sao Tome and Principe
Hygromycin B is a laboratory product manufactured by Merck Group. It is an antibiotic that inhibits protein synthesis in prokaryotic and eukaryotic cells.
Sourced in United States, Germany, France, China, United Kingdom, Italy
Hygromycin is a broad-spectrum antibiotic that is commonly used as a selection marker in genetic engineering and cell culture applications. It functions by inhibiting protein synthesis in eukaryotic cells.
Sourced in United Kingdom
The RoToR bench-top colony arrayer is a laboratory instrument designed for the automated transfer of bacterial or yeast colonies from agar plates to a new plate or other solid growth medium. The device features a robotic arm that precisely picks up and deposits colonies, enabling high-throughput screening and colony management tasks.
More about "Nourseothricin"
Nourseothricin, also known as Nourecin or NST, is a potent antibiotic derived from the bacterium Streptomyces noursei.
This natural product has a unique chemical structure, consisting of an aminoglycoside core linked to a peptide moiety.
Nourseothricin exhibits broad-spectrum antimicrobial activity, effectively inhibiting the growth of a wide range of Gram-positive and Gram-negative bacteria, as well as some fungi.
One of the primary applications of nourseothricin is in molecular biology and genetic engineering.
It is commonly used as a selection marker in vector construction and cell line development, allowing for the identification and isolation of transformed cells.
This makes it a valuable tool for researchers working with plasmids, such as those used in the creation of genetically modified organisms (GMOs).
Nourseothricin's mechanism of action involves the inhibition of protein synthesis, a crucial process for microbial survival and proliferation.
This makes it an effective antimicrobial agent, but also means it can be employed as a selective agent in various biotechnological techniques.
While nourseothricin shares some similarities with other antibiotics like ampicillin, zeocin, hygromycin B, and geneticin, it has its own unique properties and applications.
Researchers working with nourseothricin may also find the use of a rotot bench-top colony arrayer helpful in their studies.
Overall, nourseothricin is an important tool in the field of molecular biology and biotechnology, with ongoing research exploring its potential applications and mechanisms of action.
By understanding the properties and uses of this versatile antibiotic, researchers can optimize their experimental protocols and advance their studies in this dynamic area of science.
This natural product has a unique chemical structure, consisting of an aminoglycoside core linked to a peptide moiety.
Nourseothricin exhibits broad-spectrum antimicrobial activity, effectively inhibiting the growth of a wide range of Gram-positive and Gram-negative bacteria, as well as some fungi.
One of the primary applications of nourseothricin is in molecular biology and genetic engineering.
It is commonly used as a selection marker in vector construction and cell line development, allowing for the identification and isolation of transformed cells.
This makes it a valuable tool for researchers working with plasmids, such as those used in the creation of genetically modified organisms (GMOs).
Nourseothricin's mechanism of action involves the inhibition of protein synthesis, a crucial process for microbial survival and proliferation.
This makes it an effective antimicrobial agent, but also means it can be employed as a selective agent in various biotechnological techniques.
While nourseothricin shares some similarities with other antibiotics like ampicillin, zeocin, hygromycin B, and geneticin, it has its own unique properties and applications.
Researchers working with nourseothricin may also find the use of a rotot bench-top colony arrayer helpful in their studies.
Overall, nourseothricin is an important tool in the field of molecular biology and biotechnology, with ongoing research exploring its potential applications and mechanisms of action.
By understanding the properties and uses of this versatile antibiotic, researchers can optimize their experimental protocols and advance their studies in this dynamic area of science.